Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA; Department of Pathology & Cell Biology, Columbia University, New York, NY 10032, USA.
Department of Biomedical Informatics and Center for Computational Biology and Bioinformatics, Columbia University, New York, NY 10032, USA.
Cell Rep. 2014 Jan 16;6(1):130-40. doi: 10.1016/j.celrep.2013.12.027. Epub 2014 Jan 2.
Follicular lymphoma (FL) is an indolent disease, but 30%-40% of cases undergo histologic transformation to an aggressive malignancy, typically represented by diffuse large B cell lymphoma (DLBCL). The pathogenesis of this process remains largely unknown. Using whole-exome sequencing and copy-number analysis, we show here that the dominant clone of FL and transformed FL (tFL) arise by divergent evolution from a common mutated precursor through the acquisition of distinct genetic events. Mutations in epigenetic modifiers and antiapoptotic genes are introduced early in the common precursor, whereas tFL is specifically associated with alterations deregulating cell-cycle progression and DNA damage responses (CDKN2A/B, MYC, and TP53) as well as aberrant somatic hypermutation. The genomic profile of tFL shares similarities with that of germinal center B cell-type de novo DLBCL but also displays unique combinations of altered genes with diagnostic and therapeutic implications.
滤泡性淋巴瘤(FL)是一种惰性疾病,但 30%-40%的病例会发生组织学转化为侵袭性恶性肿瘤,通常表现为弥漫性大 B 细胞淋巴瘤(DLBCL)。这一过程的发病机制在很大程度上尚不清楚。本研究通过全外显子测序和拷贝数分析,结果显示 FL 和转化型 FL(tFL)的优势克隆通过共同突变前体的分歧进化而来,通过获得不同的遗传事件。表观遗传修饰和抗凋亡基因的突变发生在共同前体的早期,而 tFL 则与细胞周期进程和 DNA 损伤反应(CDKN2A/B、MYC 和 TP53)以及异常体细胞超突变调节失常相关。tFL 的基因组特征与生发中心 B 细胞型原发性 DLBCL 相似,但也显示出具有诊断和治疗意义的改变基因的独特组合。